Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2023 ▲▼ | Q1 2024 ▲▼ | Change ▲▼ | Q4 2023 ▲▼ | Q1 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Vaxcyte, Inc.(PCVX) | 579,959 | 2,750,804 | +2,170,845 | $36.42M | $187.91M | 25.02% | +$151.49M |
| Nuvalent Inc | 57,698 | 1,436,964 | +1,379,266 | $4.25M | $107.90M | 14.36% | +$103.66M |
| Keros Therapeutics, Inc.(KROS) | 1,060,427 | 1,435,950 | +375,523 | $42.16M | $95.06M | 12.65% | +$52.90M |
| Biohaven Ltd.(BHVN) | 0 | 1,476,974 | +1,476,974 | $0 | $80.78M | 10.75% | +$80.78M |
| Alpine Immune Sciences Inc | 0 | 1,982,016 | +1,982,016 | $0 | $78.57M | 10.46% | +$78.57M |
| Beam Therapeutics Inc.(BEAM) | 0 | 2,119,598 | +2,119,598 | $0 | $70.03M | 9.32% | +$70.03M |
| Apogee Therapeutics Inc | 0 | 832,198 | +832,198 | $0 | $55.30M | 7.36% | +$55.30M |
| Xencor, Inc.(XNCR) | 0 | 1,109,650 | +1,109,650 | $0 | $24.56M | 3.27% | +$24.56M |
| Spyre Therapeutics, Inc.(SYRE) | 0 | 473,200 | +473,200 | $0 | $17.95M | 2.39% | +$17.95M |
| Elevation Oncology Inc | 0 | 2,332,928 | +2,332,928 | $0 | $11.97M | 1.59% | +$11.97M |
| Tourmaline Bio Inc | 0 | 465,000 | +465,000 | $0 | $10.65M | 1.42% | +$10.65M |
| Merck & Co., Inc.(MRK) | 0 | 79,600 | +79,600 | $0 | $10.50M | 1.40% | +$10.50M |
| Ambrx Biopharma Inc | 16,688,636 | 0 | -16,688,636 | $237.65M | $0 | — | -$237.65M |
| Cytokinetics, Incorporated(CYTK) | 600,000 | 0 | -600,000 | $50.09M | $0 | — | -$50.09M |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 1,039,289 | 0 | -1,039,289 | $62.76M | $0 | — | -$62.76M |
| Springworks Therapeutics Inc | 192,734 | 0 | -192,734 | $7.03M | $0 | — | -$7.03M |
| TG Therapeutics, Inc.(TGTX) | 4,046,598 | 0 | -4,046,598 | $69.12M | $0 | — | -$69.12M |